This course has expired. View available courses.
Endocrinology
Individualising care – considerations in the escalation of pharmacological management of type 2 diabetes – QI&CPD – Category 2
Attaining optimal blood glucose management in patients with type 2 diabetes is important to improve both short-term and long-term health outcomes. A sustained legacy effect of intensive glucose-management in type 2 diabetes has been observed, indicating a continued reduction in microvascular risk. In addition, the legacy effect demonstrates an association between intensive glucose management and a significantly decreased risk of myocardial infarction and death.
A general glycaemic target of HbA1c = 7% (53mmol/mol) has therefore been recommended for newly diagnosed and uncomplicated patients. Over 60% of patients, however, are reported as not achieving their glycaemic goals. One Australian study showed less than half of patients with type 2 diabetes seen in general practice had an HbA1c = 7% (53 mmol/mol) with 25% having an HbA1c > 8% (64mmol/mol). Current glycaemic management seems to be “missing the target” of accepted treatment goals.
DURATION
2 hrs
PROFESSION
Physician
# OF CREDITS
4
ACCREDITATION
QI & CPD - Category 2
EXPIRY DATE
2020-06-29
Attaining optimal blood glucose management in patients with type 2 diabetes is important to improve both short-term and long-term health outcomes. A sustained legacy effect of intensive glucose-management in type 2 diabetes has been observed, indicating a continued reduction in microvascular risk. In addition, the legacy effect demonstrates an association between intensive glucose management and a significantly decreased risk of myocardial infarction and death.
A general glycaemic target of HbA1c = 7% (53mmol/mol) has therefore been recommended for newly diagnosed and uncomplicated patients. Over 60% of patients, however, are reported as not achieving their glycaemic goals. One Australian study showed less than half of patients with type 2 diabetes seen in general practice had an HbA1c = 7% (53 mmol/mol) with 25% having an HbA1c > 8% (64mmol/mol). Current glycaemic management seems to be “missing the target” of accepted treatment goals.
Faculty
John Eric Barlow
MBBS, MRACGP
Clinical Supervisor, University of Notre Dame, NSW
Surgical Assistant Strathfield Private Hospital, NSW
Westmead Private Hospital, NSW
Rachel Freeman
APD, CDE, BHSc (Nut&Diet), MSc (Diabetes)
Professional Services Manager
Australian Diabetes Educators Association
Accreditation
# of credits: 4
Duration: 2 hrs
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
